4.3.2 Monoamine-oxidase inhibitors (MAOIs)

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

26 library items in 4.3.2 Monoamine-oxidase inhibitors (MAOIs)

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

4: Central nervous system (remove) , 4.3 Antidepressant drugs (remove) , 4.3.2 Monoamine-oxidase inhibitors (MAOIs) (remove)

Sort by: Display summary:

Results 1 - 10 of 26

Result page:
Previous
|
1
2
3
|
Next

1.

Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome

Source: Cochrane Library,
Date published: 27/04/2012

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Drug reviews | Neurology

NeLM Area:

Evidence > Drug Class Focused Reviews

Link to Abstract
2.

Isocarboxazid Tablets 10mg- Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 01/12/2011

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Mood disorders (including depression) | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

SPC
3.

Deaths involving MDMA and the concomitant use of pharmaceutical drugs

Source: Journal of Analytical Toxicology,
Date published: 05/09/2011

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Drug Interactions | Drug Misuse | Poisoning

NeLM Area:

Evidence > Medicines Management > References

Abstract link
4.

Population based cohort study: Antidepressant use and risk of adverse outcomes in older people

Source: Health Technology Assessment (HTA), British Medical Journal (BMJ),
Date published: 03/08/2011

Category:

4.3.1 Tricyclic and related antidepressant drugs | 4.3.2 Monoamine-oxidase inhibitors (MAOIs) | 4.3.3 Selective serotonin re-uptake inhibitors | 4.3.4 Other antidepressant drugs | Adverse Drug Reactions | Care of Older People

NeLM Area:

News

HTA abstract

BMJ abstract

BMJ editorial
5.

Management of depression in breastfeeding mothers – Are reboxetine, venlafaxine, duloxetine, mirtazapine and MAOIs safe?

Source: West Midlands Medicines Information Service,
Date published: 13/05/2011
Review date: 30/04/2013

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | 4.3.4 Other antidepressant drugs | Drugs in lactation

NeLM Area:

Evidence > Medicines Q & A

QA253_2_AntidepressMisc_final.doc
6.

What is the risk of interaction between opioid analgesics and monoamine oxidase inhibitors (MAOIs)?

Source: South West Medicines Information and Training,
Date published: 08/04/2011
Review date: 28/02/2013

Category:

4.3.1 Tricyclic and related antidepressant drugs | 4.3.2 Monoamine-oxidase inhibitors (MAOIs) | 4.3.3 Selective serotonin re-uptake inhibitors | 4.3.4 Other antidepressant drugs | 4.7.2 Opioid analgesics | 4.9.1 Dopaminergic drugs used in Parkinson's disease | Adverse Drug Reactions | Drug Interactions

NeLM Area:

Evidence > Medicines Q & A

QA 192.2: Interactions between opioids and MAOIs
7.

Historical perspectives: drug interactions - it all began with cheese

Source: Journal of Internal Medicine,
Date published: 10/12/2010

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Drug Interactions

NeLM Area:

Evidence > Medicines Management > References

Extract link
8.

Combined phenelzine and CBGT superior to either treatment alone for social anxiety disorder

Source: Arch Gen Psychiatry,
Date published: 03/03/2010

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Anxiety disorders (including OCD and PTSD)

NeLM Area:

News

abstract
9.

Nardil 15mg tablets (phenelzine) - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 03/11/2009

Category:

4.3.2 Monoamine-oxidase inhibitors (MAOIs) | Mood disorders (including depression) | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

SPC
10.

If antidepressant-induced hyponatraemia has been diagnosed, how should the depression be treated?

Source: East Anglia Medicines Information Service,
Date published: 31/08/2009
Review date: 31/08/2011

Category:

4.3.1 Tricyclic and related antidepressant drugs | 4.3.2 Monoamine-oxidase inhibitors (MAOIs) | 4.3.3 Selective serotonin re-uptake inhibitors | 4.3.4 Other antidepressant drugs | Mood disorders (including depression)

NeLM Area:

Evidence > Medicines Q & A

antidephyponat2009a.doc

Results 1 - 10 of 26

Result page:
Previous
|
1
2
3
|
Next